ChemoCentryx IPO expected this week
Business Journal Sunday 5th February, 2012
Follow this company is the next Silicon Valley initial public offering expected, with its debut on Nasdaq expected this week. The Mountain View company set a target range last month of $14 to $16 for the 4 million shares it plans to sell in the IPO. The target at the top of the range would bring in $64 million, slightly less than the $6...





Comments
No comments yet for this story